Neuroleptic malignant syndrome: successful rechallenge with thioridazine.
Moysa
G D
GD
Anisete
L V
LV
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000503:physiopathology*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D013881:Thioridazine